4 курс / Акушерство и гинекология / Осипова_Н_А_Клиническое_значение_исследования_уровня_регуляторных
.pdf131
120. Dragun D., Müller D.N., Bräsen J.H., Fritsche L., Nieminen-Kelhä M., Dechend R., et al. «Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection» // The New England Journal of Medicine, 2005 Feb 10; 352(6):558
121. Easton J.D. «Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy? » //Cerebrovasc Dis, 1998 Jan, 8:1, 53-8.
122.Farina A., Barbieri M., Brown S.A., Carinci P. «Multivariate analysis for variables associated to preeclampsia» //Am J Perinatol, 1998 Jan, 15:1, 1-2.
123.Fest S., Aldo P.B., Abrahams V.M., Visintin I., Alvero A., Chen R., Chaves S.L., Romero L., Mor G. « Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy » // Am J Reprod Immunol. - 2007. – 57, 55-66.
124.Flack J.M., Peters R., Mehra V.C., Nasser S.A. «Hypertension in special populations» // Cardiology Clinics. - 2002. - V.20 (2): 303-11.
125.Gifford R.W., August P.A., Cunningham G. et al. «Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy» // Am. J. Obstet. Gynecol. - 2000. - V.183. - № 1. - P. 1-22.
126.Gomez-Lopez N., Vega-Sanchez R., Castillo-Castrejon M., Romero R., CubeiroArreola K., Vadillo-Ortega F. « Evidence for a role for the adaptive immune response in human term parturition» // Am J Reprod Immunol. – 2013. – 69. – 212-30.
127.Graham G.J. « D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes» // Eur J Immunol. – 2009. – 39. – 342-51.
128.Hamai Y., Fujii T., Yamashita T., Kozuma S., Okai T., Taketani Y. «Pathogenetic implication of interleukin-2 expressed in preeclamptic decidual tissues: a possible mechanism of deranged vasculature of the placenta associated with preeclampsia»//Am J Reprod Immunol, 1997 Aug, 38:2, 83-8.
129.Hawkins T.L., Roberts J.M., Mangos G.J., Davis G.K., Roberts L.M., Brown M.A. «Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study» // BJOG, 2012;119:484–92.
132
130.Heintzel K., Benz C., Bleul C. « Evidence for a role for the adaptive immune response in human term parturition» // Proc Natl Acad Sci U S A. – 2007. – 104 – 8421-6.
131.Hermida R.C., Ayala D.E., Mojón A., Fernández J.R, Silva I., Ucieda R., Iglesias M. «High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia. Early detection of gestational hypertension and preeclampsia by the computation of a hyperbaric index» //J Perinat Med, 1997, 25:3, 254-73.
132.Herrmann M., Kalden J.R. (eds.) «Apoptosis and autoimmunity», WILEY-WCH, Weinheim, 2003г. P. 387.
133.Higgins J.R., Brennecke S.P. «Preeclampsia still a disease of theories? » //Curr Opin Obstet Gynecol, 1998 Apr, 10:2, 129-33.
134.Higgins J.R., Papayianni A., Brady H.R, Darling M.R, Walshe J.J. «Circulating vascular cell adhesion molecule-1 in preeclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in preeclampsia.» //Am J Obstet Gynecol, 1998 Aug, 179:2, 464-9.
135.Hill E, Clarke M., Barr F.A. «The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis»// EMBO J. 2000 Nov 1; 19(21):5711-9.
136.Holzgreve W., Ghezzi F., Di Naro E., Gnshirt D.,Maymon E., Hahn S. «Disturbed feto-maternal cell traffic in preeclampsia. » //Obstet Gynecol, 1998 May, 91:5 Pt 1, 669-72.
137.Ivanisevic M., Segerer S., Rieger L., Kapp M., Dietl J., Kammerer U., Frambach T. « Antigen-presenting cells in pregnant and non-pregnant human myometrium »// Am J Reprod Immunol, 2010, 64, 188-96.
138.Kashihara N., Sugiyama H., Makino H. « Implication of apoptosis in progression of renal disease» // Contrib. Nephrol. - 2003, Vol. 139:156-172.
139.Lash G.E., Robson S.C., Bulmer J.N. « Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua» // Placenta. - 2010, 31 Suppl, S87-92.
133
140. Le Gall S.M., Legrand J., Benbijja M., Safya H., Benihoud K., Kanellopoulos J.M., Bobe P. « Loss of P2X7 Receptor Plasma Membrane Expression and Function in Pathogenic B220(+) Double-Negative T Lymphocytes of Autoimmune MRL/lpr Mice» //. PLoS One, 2012, 7, e52161.
141. Levine J., Branch D.W., Rauch J. «The antiphospholipid syndrome. » // N Engl J Med 2002; 346:752—763.
142. Lee S.K., Kim J.Y., Lee M., Gilman-Sachs A., Kwak-Kim J. « Th17
and regulatory T cells in women with recurrent pregnancy loss»// Am J Reprod Immunol, 2012, 67, 311-8.
143.Lydakis C., Beevers M., Beevers D.G., Lip G.Y. « The prevalence of preeclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic »// Int J Clin Pract, 2001 Jul-Aug; 55(6):361-7.
144.Magee L.A., Duley L. «Oral beta-blockers for mild to moderate hypertension during pregnancy»// Cochrane Database Syst. Rev. - 2003. - 3:CD002863.
145.Magno G., Joris I. «Apoptosis, oncosis, necrosis» // Amer. J.Pathol. 1995, v.146, N, 1, p.3-15.
146.Melgert B.N., Spaans F., Borghuis T., Klock P.A., Groen B., Bolt A., De Vos P., Van Pampus M.G., Wong T.Y., Van Goor H., Bakker W.W., Faas M.M. « Pregnancy and preeclampsia affect monocyte subsets in humans and rats » // PLoS One, 2012, 7, e45229.
147.Moschovakis G.L., Forster R. « Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease» // Eur J Immunol, 2012, 42, 1949-55.
148.Notkins A.L. «New predictors of disease» //J. Scientific American. 2007; 296 (3): 54–62.
149.Orbak Z., Zor N., Energin V.M., Selimoglu M.A., Handan A.L., Akзay F. « Endothelin-1 levels in mothers with eclampsia--pre-eclampsia and their newborns»//J Trop Pediatr, 1998 Feb, 44:1, 47-9.
134
150.Poon L.C., Kametas N.A., Maiz N., Akolekar R., Nicolaides K.H. «Firsttrimester prediction of hypertensive disorders in pregnancy»// Hypertension, 2009, 53:812–8.
151.Poletaev А., Osipenko L. «General network of natural autoantibodies as Immunological Homunculus (Immunculus) ». Autoimmunity Review, 2003 г. - 2, 5, 264–271.
152. Poletaev A.B., Morozov S.G. « Changes of maternal serum natural antibodies of IgG class to proteins МBP, S100, ACBP14/18 and MP65 and embryonic misdevelopments in humans»// Human Antibody 2000, 9, 4, 216-222.
153.Powers R.W., Jeyabalan A., Clifton R.G., Van Dorsten P., Hauth J.C., Klebanoff M.A., et al. « Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies»// Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network. PLoS One, 2010, 5, e13263.
154.Raijmakers M. T. «Oxidative stress and preeclampsia: rationale for antioxidant clinical trials» / M. T. Raijmakers, R. Dechend, L. Poston // Hypertension.– 2004. – Vol. 44, No 4. – P. 374–380.
155. Sakamoto S., Terao T. «How to lower perinatal mortality? Perinatal care in Japan»//Croat Med J, 1998 Jun, 39:2, 197-207.
156.Schuiling GA., Koiter TR., Faas MM. «Why pre-eclampsia? » //Hum Reprod, 1997 Oct, 12:10, 2087-91.
157.Sibai B.M. « Etiology and management of postpartum hypertensionpreeclampsia » // Am J Obstet Gynecol, 2012, 206:470–5.
158.Sibai B.M. «Evaluation and management of severe preeclampsia before 34 weeks' gestation. Publications Committee, Society for Maternal-Fetal Medicine » // Am J Obstet Gynecol, 2011; 205:191–8.
159.Sibai B.M. «Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia » // Semin Perinatol, 2011, 35:292–6.
135
160.Spinnato J.A., Freire S., Pinto E. Silva J.L., Cunha Rudge M.V., Martins-Costa S., Koch M.A., et al. .« Antioxidant therapy to prevent preeclampsia: a randomized controlled trial »// Obstet Gynecol, 2007;110:1311–8.
161.Takakuwa K., Arakawa M., Tamura M., Hataya I., Higashino M., Yasuda M., Tanaka K. «HLA antigens in patients with severe preeclampsia»//J Perinat Med, 1997, 25:1, 79-83.
162.Taylor R.N. «Review: immunobiology of preeclampsia»//Am J Reprod Immunol, 1997 Jan, 37:1, 79-86.
163.Tin-Wing Yen, Payne B., Ziguang Qu, Hutcheon J.A., Tang Lee, Magee L.A., Walters B.N., Von Dadelszen P. « Using Clinical Symptoms to Predict Adverse Maternal and Perinatal Outcomes in Women With Preeclampsia: Data From the PIERS (Pre-eclampsia Integrated Estimate of RiSk) Study»//Obstetrics, 2011, august, 803-9.
164.Verlohren S., Muller D.N., Luft F.C., Dechend R. «Immunology in hypertension, preeclampsia, and target-organ damage»// Hypertension - 2009;54:439-43.
165.Wang A., Rana S., Karumanchi S.A. « Preeclampsia: the role of angiogenic factors in its pathogenesis» // Physiology (Bethesda), 2009;24:147–58.
166.Xia Y., Kellems R.E. « Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond» // Circ Res., 2013;113(1):78-87.
167.Zhou C.C., Ahmad S., Mi T., Abbasi S., Xia L., Day M.C., Ramin S.M., Ahmed A., Kellems R.E., Xia Y. «Autoantibody from women with preeclampsia induces soluble fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated t-cells signaling» //Hypertension - 2008, 51:1010-1019.
168.Zhou C.C., Zhang Y., Irani R.A., Zhang H., Mi T., Popek E.J., et al. «Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice » // Nat Med , 2008, ;14:855–62.